维普中文期刊产品整合服务
78篇 您的检索式:作者名="Arbuthnot"
    题名 作者 年代 出处 被引量
1Harnessing the RNA interference pathway to advance treatment and prevention of hepatocellular carcinoma显示文摘Primary liver cancer is the fifth most common malignan- cy in the world and is a leading cause of cancer-related mortality.Available treatment for hepatocellular carcino- ma(HCC),the commonest primary liver cancer,is rarely curative and there is a need to develop therapy that is more effective.Specific and powerful gene silencing that can be achieved by activating RNA interference(RNAi) has generated enthusiasm for exploiting this pathway for HCC therapy.Many studies have been carried out with the aim of silencing HCC-related cellular oncogenes or the hepatocarcinogenic hepatitis B virus(HBV)and hepatitis C virus(HCV).Proof of principle studies have demonstrated promising results,and an early clinical trial assessing RNAi-based HBV therapy is currently in progress.Although the data augur well,there are several significant hurdles that need to be overcome before the goal of RNAi-based therapy for HCC is realized.Particu- larly important are the efficient and safe delivery of RNAi effecters to target malignant tissue and the limitation of unintended harmful non-specific effects.Patrick Arbuthnot Liam Jed Thompson 2008World Journal of Gastroenterology2008,14,11:14
2Hepatitis B virus and hepatocellular cardnoma显示文摘Arbuthnot P Kew M 2001In J Exp Pathol2001,82,2:1
3Putative role of hepatitis B virus X protein in hepatocarcinogenesis: Effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways显示文摘Arbuthnot P Capovilla P Kew M 2000J Gastroenterol Hepatol2000,15,:1
4Regulatory elements of hepatitis B virus transcription 显示文摘Moolla N Kew M Arbuthnot P 2002J Viral Hepat2002,9,5:1
5Countering hepatitis B virus infection using RNAi:how far are we from the clinic显示文摘Ivacik D Ely A Arbuthnot P 0,,6:1
6Opportunities for treating chronic hepatitis B and C virus infection using RNA interference显示文摘Arbuthnot P Longshaw V Naidoo T 0,,8:1
7Hepatitis B virus and hepatocellular carcinoma显示文摘Arbuthnot P Kew M 2001Int J Exp Pathol2001,82,2:1
8Hepatitis B virus and hepatocellular carcinoma显示文摘Arbuthnot P Kew M 2001Int J Exp Pathol2001,82,:1
9Putative role of hepatitis B virus X protein in hepatocarcinogenesis:effect on apoptosis, DNA repair, mitogen-activatedprotein kinase and JAK/STAT pathways显示文摘Arbuthnot P Capovilla A Kew M 2000J Gastroenterol Hepatol2000,15,4:1
10Hepatitis B virus and hepatocellular carcinoma显示文摘 Kew M 2001Int J Exp Pathol2001,82,:1
11Regulatory elements othepatitis B virus transcription 显示文摘Moolla N Kew M Arbuthnot P 2002J Viral Hepat2002,9,5:1
12Remarks on the results of operative treatment of chronic constipation显示文摘Arbuthnot LW 1908BMJ1908,1,2455:1
13Hepatitis B Virus and hepatocellular carcinoma 显示文摘Arbuthnot P Kew M 2001International journal of experimental pathology2001,82,2:1
14RNA interference-based gene expression strategies aimed at sustained therapeutic inhibition of HIV 显示文摘Barichievy S Saayman S Arbuthnot P 2009Curr Top Med Chem2009,9,12:1
15A Comparison of French and American Environmental Behaviors, Knowledge and Attitudes显示文摘Arbuthnot J Lingg S 1975International Journal of Psychology1975,10,4:1
16Putative role of hepatitis B virus X protein in hepatocarcinogenesis: effects on apoptosis, DNA repair, mitogen - activated protein kinase and JAK/STAT pathways显示文摘Arbuthnot P Capovilla A Kew M 2000J Gastroenterol Hepatol2000,15,4:1
17Hepatitis B virus and hepatocellular carcinoma显示文摘Arbuthnot P Kew M 0,,2:1
18Hepatitis B virus and hepatocellular carcinoma显示文摘Arbuthnot P Kew M 2001Int J Exp Pathol2001,82,2:1
19Hepatitis B virus and hepatocellular carcinoma 显示文摘Arbuthnot P Kew M 2001Int J Exp Pathol2001,82,2:1
20Hepatitis B virus and hepatocellular carci- noma 显示文摘Arbuthnot P Kew M 2001Int J Exp Pathol2001,82,2:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费